SHAH ALAM: Vaccinating children aged 3 to 11 years will likely be necessary to reach herd immunity at a faster pace in supporting our race to protect the whole population against the COVID-19 pandemic.
With the highly contagious Wuhan and other variants spreading in communities across the country and schools will reopen next year, parents are eager for children of all ages to have protection against COVID-19 virus infection.
Currently, only children aged 12 to 17 years are eligible to be vaccinated with the COVID-19 vaccine, but it would soon become available for younger age groups.
The Sinovac COVID-19 vaccine has been approved in China for children aged 3 to 17 years.
The majority of adverse effects were either mild or moderate and were most likely to be the common pain at the
injection site.
Dr Alexis M. Kalergis, Professor and Director of Immunology and Immunotherapy Millennium Institute from Chile said based on the pediatric population in China’s vaccinated children, the vaccine has shown a high safety and efficacy result.
“Here in Chile, the inactivated vaccines are commonly used amongst the population for other diseases such as polio and hepatitis.
We have received a high recommendation from the Ministry of Health and Scientific Committee, where they have been supporting the approval for the emergency use of COVID-19 vaccine in children aged 6 and above.
“To date, it has been moving efficiently and the adverse effect are very rare. And of course, in our study, we have collected good data for its safety and efficacy,” he said during a virtual webinar entitled “COVID-19 Booster Shots and Vaccination for Children: Moving forward with experiences from China, Chile and Indonesia” organised by Pharmaniaga Berhad recently.
Dr M. Rahman Roestan, Operational Director of PT Bio Farma and Vice-Chairman OIC – VMG from Indonesia said the deployment of children vaccination is important to reach herd immunity.
“Based on the Indonesian health expert perspective, more clinical trials are necessary to determine the safety and efficacy of the COVID-19 vaccine amongst the children.
After we have reached approximately 70% of the adult population, children vaccination has started right after.
“This pandemic has impacted many people, especially children. Mostly, it will affect their social skills, education, physical and mental health, as well as limited social interaction.
We have retrieved the data that 78% of parents agree to vaccinate their children once the vaccine is available,” said Dr M Rahman, who is also one of the speakers in the webinar.
He said more than 64% of parents have agreed to send their children to school if the authority implemented strict protocols.
“We are now in the midst of registration for children aged 3 to 17 years and have submitted clinical trials for phase I and II to the Indonesian’s National Risk Assessment (NRA), the result looks promising based on its safety profile.”
Currently, Sinovac COVID-19 global clinical trial has started in South Africa with Chile, Philippines, Indonesia, Malaysia and Kenya participating for children aged 3 to 17 years.
With the total number of children under 18 which make up a significant proportion of 28.3% in Malaysia’s population of 32.7 million in 2020, according to the Children Statistics for Malaysia 2020, it concluded that the faster we can vaccinate all children and adolescent in the country, we can achieve herd immunity against the COVID-19.
Speaking on the halalan toyyiban (allowed and permissible for consumption with relation to Syariah law as long as they are safe and not harmful) aspect, Dr M Rahman said as a country with the most Muslim population globally, it is vital to consider the halalan toyyiban aspect.
“For the COVID-19 vaccine, we realised that safety, quality and efficacy is our main priority. When we finalised Sinovac as our partner, we consulted our Ulama council and regulatory authority to audit the Sinovac site in China.
“They reviewed the site of the vaccine manufacturing plant, material and equipment used, which gives no doubts about its halalan toyyiban. Hence, we have successfully obtained Halal certification in Indonesia.”
Besides Dr Alexis and Dr M Rahman, other speakers who participated in the webinar were Dr Ajit Pal Singh, Head of Biologic/Vaccine Specialist of Pharmaniaga Berhad, Dr Badarulhisam Abdul Rahman, Head of Research and Development of Pharmaniaga Berhad and Mr Weining Meng, Senior Director of Oversea Business, Sinovac Biotech Co Ltd from China.
Pharmaniaga is the leading pharmaceutical Company of Boustead Holdings Berhad group of companies, and together with Lembaga Tabung Angkatan Tentera, are the major shareholders of the Company.
Media Statement
Fri Oct 15 2021
Currently, only children aged 12 to 17 years are eligible to be vaccinated with the COVID-19 vaccine, but it would soon become available for younger age groups. - File photo
Kim Pan-gon akan ke Ulsan Hyundai?
Bekas pengendali skuad negara itu dilaporkan sedang menjadi calon utama untuk mengisi jawatan pengurus kelab gergasi Korea Selatan, Ulsan Hyundai.
Lebih 2,300 hektar kawasan lapang di ibu negara diperuntukkan kawasan hijau
Daripada keluasan itu, sebanyak 977.55 hektar tanah telah diwartakan, manakala 1,416.24 hektar tanah lapang yang berpotensi akan dan sedang dalam proses diwartakan.
Guna jawatan untuk projek pembekalan, suami isteri ditahan
Sepasang suami isteri direman enam hari dalam siasatan penyalahgunaan jawatan untuk mendapatkan projek pembekalan bernilai lebih RM200,000.
Perintah reman dikeluarkan Majistret Noor Mazrinie Mahmood bermula hari ini hingga Ahad.
Perintah reman dikeluarkan Majistret Noor Mazrinie Mahmood bermula hari ini hingga Ahad.
DBKL ubah lalu lintas Jalan Sultan Ismail bermula 22 Julai
Dewan Bandaraya Kuala Lumpur (DBKL) akan melaksanakan perubahan lalu lintas di Jalan Sultan Ismail berkuat kuasa 22 Julai ini.
ADUN Rembia sertai Pas, kenapa tak umum tahun lepas? - MP Kampar
Tindakan tersebut seolah-olah satu penghinaan paling besar kepada Parlimen yang telah meluluskan pindaan Perlembagaan Persekutuan berkait Akta Antilompat Parti.
[TERKINI] Perbelanjaan pengguna Malaysia dijangka kembali teguh
Perbelanjaan pengguna Malaysia dijangka teguh sepanjang tahun ini, demikian menurut BMI, iaitu syarikat Fitch Solitions.
Kes bunuh Nur Farah Kartini: Suspek berkhidmat 5 tahun dalam PDRM
Anggota berusia 26 tahun terbabit bertugas di Balai Polis Slim River di bawah Ibu Pejabat Polis Daerah (IPD) Muallim dengan pangkat lans koperal.
Perunding pelaburan didakwa terlibat pengubahan wang haram hampir RM1 juta
Seorang perunding pelaburan mengaku tidak bersalah atas empat pertuduhan pengubahan wang haram berjumlah hampir RM1 juta.
Purata suhu meningkat 0.24 darjah celcius per dekad
Berdasarkan rekod dari tahun 1969 hingga 2019, purata suhu bulanan di Semenanjung Malaysia pada bulan Mei 2024 adalah 28.8 darjah celcius manakala purata suhu bulanan pada bulan Mei 1974 iaitu 50 tahun yang lalu adalah 26.6 darjah celcius.
ADUN dari kerajaan perpaduan sertai Pas
Menurut Takiyuddin, keahlian Muhamad Jailani yang juga wakil rakyat UMNO diterima pada 10 Jun tahun lalu, namun diumumkan secara rasmi hari ini.
Penduduk Singapura boleh pilih vaksin COVID-19
Kerajaan Singapura menyasarkan kesemua penduduk divaksin menjelang hujung tahun ini.
Ini senarai negara yang gantung penggunaan vaksin AstraZeneca
Indonesia antara negara terbaharu yang menggantung pemberian vaksin COVID-19 buatan AstraZeneca.
Vaksin Sinovac tiba di Malaysia pada 27 Februari
Vaksin Sinovac dijangka mula dibotolkan pada Februari sebelum diedarkan pada Mac oleh Pharmaniaga.
Berita antarabangsa pilihan sepanjang hari ini
Antara pelbagai berita luar negara yang disiarkan di Astro AWANI, berikut adalah antara yang paling menjadi tumpuan sepanjang hari ini.
Bekalan vaksin COVID-19 AstraZeneca ke EU dikurangkan
Bekalan dos vaksin syarikat itu ke EU dikurangkan sebanyak 60 peratus, daripada 80 juta kepada 31 juta dos pada suku pertama 2021.
Pelan vaksin COVID-19 negara ambil masa 18 bulan - Khairy
Dewasa sihat bawah usia 60 tahun dan bukan merupakan petugas barisan hadapan dijangka hanya dapat menerima vaksin pada suku ketiga tahun ini atau kemudian.
COVID-19: Kerjasama semua pihak mampu capai imuniti kelompok
Usaha kerajaan melaksanakan Perintah Kawalan Pergerakan (PKP) disifatkan relevan, sementara negara berusaha mencapai tahap imuniti kelompok.
COVID-19: Imuniti kelompok tidak akan tercapai pada 2021 dengan vaksin - Pakar
Jelas seorang pakar, kebergantungan kerajaan kepada vaksin dan kurang perhatian kepada aspek lain tidak akan bantu mencapai kelompok imuniti.
COVID-19: Vietnam bersetuju beli 30 juta dos vaksin AstraZeneca
Vietnam turut sedang berunding untuk mendapatkan vaksin Pfizer, Sputnik V dari Rusia dan vaksin dari China.
US poised to hit 16 million COVID-19 cases within days even as vaccine begins rollout
The United States is poised to hit a record 16 million COVID-19 cases in the coming days and deaths are closing in on the 300,000 mark.